[HTML] thelancet.com

[HTML][HTML] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel, Á McKnight… - The Lancet, 2021 - thelancet.com
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals - The
Lancet Skip to Main Content Advertisement The Lancet Journal Submit Article Log in Register …
被引用次数：438 相关文章

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel… - Lancet (London …, 2021 - pubmed.ncbi.nlm.nih.gov
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals …

[引用][C] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel, Á McKnight… - The …, 2021 - researchportal.ukhsa.gov.uk
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals —
UK Health Security Agency Skip to main navigation Skip to search Skip to main content UK …
[HTML] nih.gov

[HTML][HTML] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel, Á McKnight… - Lancet (London …, 2021 - ncbi.nlm.nih.gov
Rapid vaccine-induced population immunity is a key global strategy to control COVID-19.
Vaccination programmes must maximise early impact, particularly with accelerated spread …
[PDF] ucl.ac.uk

[PDF][PDF] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.

C Manisty, AD Otter, TA Treibel, Á McKnight… - Lancet, 2021 - discovery.ucl.ac.uk
1 Title Enhanced antibody responses to first vaccine dose in previously SARS-CoV-2 infected
individuals may render the booster d Page 1 1 Title Enhanced antibody responses to first …

Antibody response to first bnt162b2 dose in previously SARS-CoV-2-infected individuals.

C Manisty, AD Otter, TA Treibel, Á McKnight… - 2021 - cabidigitallibrary.org
All participants received their first dose of the BNT162b2 mRNA COVID-19 vaccine (Pfizer-
BioNTech, Mainz, Germany) and were tested 19-29 days later (median 22 days, IQR 2) …

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.

C Manisty, AD Otter, TA Treibel, Á McKnight… - Lancet (London …, 2021 - europepmc.org
Rapid vaccine-induced population immunity is a key global strategy to control COVID-19.
Vaccination programmes must maximise early impact, particularly with accelerated spread …

[引用][C] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel, A McKnight… - LANCET, 2021 - qmro.qmul.ac.uk
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Toggle navigation Login Toggle navigation Antibody response to first BNT162b2 dose in …

[引用][C] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel, Á McKnight… - The Lancet, 2021 - cir.nii.ac.jp
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

[引用][C] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

C Manisty, AD Otter, TA Treibel, Á McKnight… - The Lancet, 2021 - thelancet.com
Rapid vaccine-induced population immunity is a key global strategy to control COVID-19.
Vaccination programmes must maximise early impact, particularly with accelerated spread …